KAPA
Price
$0.37
Change
-$0.00 (-0.00%)
Updated
Jul 2 closing price
Capitalization
7.92M
59 days until earnings call
Intraday BUY SELL Signals
LIXT
Price
$7.26
Change
+$0.07 (+0.97%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
125.36M
Intraday BUY SELL Signals
Interact to see
Advertisement

KAPA vs LIXT

KAPA vs LIXT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KAPA vs. LIXT commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KAPA is a Hold and LIXT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2026
Stock price -- (KAPA: $0.37 vs. LIXT: $7.19)
Brand notoriety: KAPA and LIXT are both not notable
KAPA represents the Biotechnology, while LIXT is part of the Electrical Products industry
Current volume relative to the 65-day Moving Average: KAPA: 69% vs. LIXT: 87%
Market capitalization -- KAPA: $7.92M vs. LIXT: $125.36M
KAPA [@Biotechnology] is valued at $7.92M. LIXT’s [@Electrical Products] market capitalization is $125.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $134.02B to $0. The market cap for tickers in the [@Electrical Products] industry ranges from $300.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B. The average market capitalization across the [@Electrical Products] industry is $6.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KAPA’s FA Score shows that 1 FA rating(s) are green whileLIXT’s FA Score has 0 green FA rating(s).

  • KAPA’s FA Score: 1 green, 4 red.
  • LIXT’s FA Score: 0 green, 5 red.
According to our system of comparison, LIXT is a better buy in the long-term than KAPA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KAPA’s TA Score shows that 4 TA indicator(s) are bullish while LIXT’s TA Score has 4 bullish TA indicator(s).

  • KAPA’s TA Score: 4 bullish, 4 bearish.
  • LIXT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KAPA is a better buy in the short-term than LIXT.

Price Growth

KAPA (@Biotechnology) experienced а -1.25% price change this week, while LIXT (@Electrical Products) price change was +8.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.30%. For the same industry, the average monthly price growth was +5.93%, and the average quarterly price growth was +1921.84%.

The average weekly price growth across all stocks in the @Electrical Products industry was -2.22%. For the same industry, the average monthly price growth was -8.38%, and the average quarterly price growth was +7.61%.

Reported Earning Dates

KAPA is expected to report earnings on Sep 02, 2026.

Industries' Descriptions

@Biotechnology (+2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Electrical Products (-2.22% weekly)

The industry produces a diverse range of electricity-powered equipment, appliances and components, catering to both households and industries. The products include power, distribution and specialty transformers; electric motors, generators and motor-generator sets; switchgear and switchboard apparatus; light bulbs, tubes, fittings and electric signs etc. Consumer income, construction spending, and industrial production are major drivers of demand for this industry’s products. Large companies tend to have economies of scale in production, marketing, and distribution, while smaller companies can potentially carve out their own market through niche or specialty offerings. The US electrical products manufacturing industry includes about 5,700 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $125 billion. (according to a study published in First Research). Emerson Electric Co., Hubbell Incorporated and Eaton Corporation plc are major electrical products makers in the U.S.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LIXT($125M) has a higher market cap than KAPA($7.92M). LIXT YTD gains are higher at: 82.952 vs. KAPA (-47.873). KAPA has higher annual earnings (EBITDA): -5.71M vs. LIXT (-7.28M). KAPA has more cash in the bank: 3.68M vs. LIXT (3.25M). KAPA has less debt than LIXT: KAPA (142K) vs LIXT (595K). KAPA (0) and LIXT (0) have equivalent revenues.
KAPALIXTKAPA / LIXT
Capitalization7.92M125M6%
EBITDA-5.71M-7.28M78%
Gain YTD-47.87382.952-58%
P/E RatioN/AN/A-
Revenue00-
Total Cash3.68M3.25M113%
Total Debt142K595K24%
FUNDAMENTALS RATINGS
LIXT: Fundamental Ratings
LIXT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KAPALIXT
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 17 days ago
86%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
KAPA
Daily Signal:
Gain/Loss:
LIXT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QSR74.793.33
+4.66%
Restaurant Brands International
GNW9.610.06
+0.63%
Genworth Financial
NXL0.35N/A
N/A
Nexalin Technology
LXU10.64N/A
N/A
LSB Industries
OGI1.03N/A
N/A
Organigram Global Inc

KAPA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KAPA has been loosely correlated with INKT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if KAPA jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAPA
1D Price
Change %
KAPA100%
+0.54%
INKT - KAPA
50%
Loosely correlated
N/A
BGMS - KAPA
46%
Loosely correlated
N/A
QTTB - KAPA
29%
Poorly correlated
N/A
LIXT - KAPA
24%
Poorly correlated
N/A
PHIO - KAPA
24%
Poorly correlated
N/A
More

LIXT and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIXT has been loosely correlated with PTHS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LIXT jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIXT
1D Price
Change %
LIXT100%
N/A
PTHS - LIXT
34%
Loosely correlated
-7.96%
HYPD - LIXT
31%
Poorly correlated
N/A
NTLA - LIXT
28%
Poorly correlated
N/A
IBIO - LIXT
28%
Poorly correlated
N/A
BBIO - LIXT
27%
Poorly correlated
N/A
More